Pharmacy

SAVA Medica Limited is a leading pharmaceutical company based in India.
Human life is precious to us. That is why we, at SAVA Medica, are committed to provide such products which can improve human health & life at affordable cost.
To accomplish our aim we, at SAVA Medica, are engaged in manufacturing & marketing of the branded generic medicines at affordable prices.

Ecron Acunova is a CRO combining the strengths from four previously independent expert CROs on two continents serving established clinical research geographies of Europe, India and South East Asia (SEA). This integration enabled the four expert CRO’s to increase the value to sponsors with patient recruitment in India, SEA, Nordic countries, West Europe and East Europe with faster patient enrolment in clinical trials and timely database lock. It added services of early development and central lab.

The Razi Advantage comes from linking the entrepreneurial energy of their doctors to a brand that patients can trust. With the Razi Clinics brand, they offer a patient-centred approach to health care with a guarantee of affordability.

Post: Pharmacits

Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram is an Institute of National Importance  established by an Act  of the Indian Parliament  and  under the 2 administrative control of the Department of Science and Technology, Government of India.

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.